Fibrinogen and clot-related phenotypes determined by fibrinogen polymorphisms: Independent and IL-6-interactive associations HT Cronje, C Nienaber-Rousseau, L Zandberg, Z De Lange, FR Green, ... PLoS One 12 (11), e0187712, 2017 | 45 | 2017 |
Serum NfL and GFAP are associated with incident dementia and dementia mortality in older adults: the cardiovascular health study HT Cronjé, X Liu, MC Odden, KF Moseholm, S Seshadri, CL Satizabal, ... Alzheimer's & Dementia 19 (12), 5672-5680, 2023 | 23 | 2023 |
Replication and expansion of epigenome-wide association literature in a black South African population HT Cronjé, HR Elliott, C Nienaber-Rousseau, M Pieters Clinical epigenetics 12, 1-13, 2020 | 22 | 2020 |
Mendelian randomization applied to neurology: promises and challenges E Gagnon, I Daghlas, L Zagkos, M Sargurupremraj, MK Georgakis, ... Neurology 102 (4), e209128, 2024 | 17 | 2024 |
A drug target for erectile dysfunction to help improve fertility, sexual activity, and wellbeing: mendelian randomisation study B Woolf, S Rajasundaram, HT Cronjé, J Yarmolinsky, S Burgess, D Gill bmj 383, 2023 | 16 | 2023 |
Genetic evidence implicating natriuretic peptide receptor-3 in cardiovascular disease risk: a Mendelian randomization study HT Cronjé, V Karhunen, GK Hovingh, K Coppieters, JO Lagerstedt, ... BMC medicine 21 (1), 158, 2023 | 16 | 2023 |
Plasma antioxidants and risk of dementia in older adults M Koch, JD Furtado, HT Cronjé, ST DeKosky, AL Fitzpatrick, OL Lopez, ... Alzheimer's & Dementia: Translational Research & Clinical Interventions 7 (1 …, 2021 | 16 | 2021 |
Candidate gene analysis of the fibrinogen phenotype reveals the importance of polygenic co-regulation HT Cronje, C Nienaber-Rousseau, L Zandberg, T Chikowore, Z de Lange, ... Matrix biology 60, 16-26, 2017 | 16 | 2017 |
Epigenetic-age acceleration in the emerging burden of cardiometabolic diseases among migrant and non-migrant African populations: a population-based cross-sectional RODAM substudy FP Chilunga, P Henneman, HR Elliott, HT Cronjé, GK Walia, KAC Meeks, ... The Lancet Healthy Longevity 2 (6), e327-e339, 2021 | 14 | 2021 |
Incorporating biological and clinical insights into variant choice for Mendelian randomisation: examples and principles S Burgess, HT Cronjé Egastroenterology 2 (1), 2024 | 13 | 2024 |
Appraising the causal relationship between plasma caffeine levels and neuropsychiatric disorders through Mendelian randomization B Woolf, HT Cronjé, L Zagkos, S Burgess, D Gill, SC Larsson BMC medicine 21 (1), 296, 2023 | 9 | 2023 |
Sphingomyelins and ceramides: possible biomarkers for dementia? LMI Loft, KF Moseholm, KKW Pedersen, MK Jensen, M Koch, HT Cronje Current Opinion in Lipidology 33 (1), 57-67, 2022 | 9 | 2022 |
Renoprotective effects of genetically proxied fibroblast growth factor 21: Mendelian randomization, proteome-wide and metabolome-wide association study A Giontella, L Zagkos, M Geybels, SC Larsson, I Tzoulaki, CS Mantzoros, ... Metabolism 145, 155616, 2023 | 8 | 2023 |
Caffeine Intake, Plasma Caffeine Level, and Kidney Function: A Mendelian Randomization Study A Giontella, R de La Harpe, HT Cronje, L Zagkos, B Woolf, SC Larsson, ... Nutrients 15 (20), 4422, 2023 | 7 | 2023 |
The association between an energy-adjusted dietary inflammatory index and inflammation in rural and urban Black South Africans M Ferreira, HT Cronjé, T Van Zyl, N Bondonno, M Pieters Public Health Nutrition 25 (12), 3432-3444, 2022 | 7 | 2022 |
Comparison of DNA methylation clocks in Black South African men HT Cronje, C Nienaber-Rousseau, JL Min, FR Green, HR Elliott, M Pieters Epigenomics 13 (06), 437-449, 2021 | 7 | 2021 |
Leveraging the urban–rural divide for epigenetic research HT Cronje, HR Elliott, C Nienaber-Rousseau, M Pieters Epigenomics 12 (12), 1071-1081, 2020 | 7 | 2020 |
Plasma proteomic risk markers of incident type 2 diabetes reflect physiologically distinct components of glucose-insulin homeostasis HT Cronjé, MY Mi, TR Austin, ML Biggs, DS Siscovick, RN Lemaitre, ... Diabetes 72 (5), 666-673, 2023 | 6 | 2023 |
Comparison of caffeine consumption behavior with plasma caffeine levels as exposures in drug-target Mendelian randomization and implications for interpreting effects on obesity B Woolf, HT Cronjé, L Zagkos, SC Larsson, D Gill, S Burgess medRxiv, 2023.05. 30.23290752, 2023 | 5 | 2023 |
Comparison of caffeine consumption behavior with plasma caffeine levels as exposure measures in drug-target Mendelian randomization B Woolf, HT Cronjé, L Zagkos, SC Larsson, D Gill, S Burgess American Journal of Epidemiology, kwae143, 2024 | 4 | 2024 |